SEVAL, G. Et Al. 2014. Nilotinib a second generation tyrosine kinase inhibitor does not effect spermatogenesis within chronic myeloid leukemia treatment dose ranges in mouse model. 10th Biennial Conference of Alpha, Scientists in reproductive Medicine , (Antalya, Turkey).

SEVAL, G., SEVAL, M. M., & ÖZKAVUKCU, İ. S., (2014). Nilotinib a second generation tyrosine kinase inhibitor does not effect spermatogenesis within chronic myeloid leukemia treatment dose ranges in mouse model . 10th Biennial Conference of Alpha, Scientists in reproductive Medicine, Antalya, Turkey

SEVAL, GÜLDANE, MEHMET MURAT SEVAL, And İSKENDER SİNAN ÖZKAVUKCU. "Nilotinib a second generation tyrosine kinase inhibitor does not effect spermatogenesis within chronic myeloid leukemia treatment dose ranges in mouse model," 10th Biennial Conference of Alpha, Scientists in reproductive Medicine, Antalya, Turkey, 2014

SEVAL, GÜLDANE C. Et Al. "Nilotinib a second generation tyrosine kinase inhibitor does not effect spermatogenesis within chronic myeloid leukemia treatment dose ranges in mouse model." 10th Biennial Conference of Alpha, Scientists in reproductive Medicine , Antalya, Turkey, 2014

SEVAL, G. SEVAL, M. M. And ÖZKAVUKCU, İ. S. (2014) . "Nilotinib a second generation tyrosine kinase inhibitor does not effect spermatogenesis within chronic myeloid leukemia treatment dose ranges in mouse model." 10th Biennial Conference of Alpha, Scientists in reproductive Medicine , Antalya, Turkey.

@conferencepaper{conferencepaper, author={GÜLDANE CENGİZ SEVAL Et Al. }, title={Nilotinib a second generation tyrosine kinase inhibitor does not effect spermatogenesis within chronic myeloid leukemia treatment dose ranges in mouse model}, congress name={10th Biennial Conference of Alpha, Scientists in reproductive Medicine}, city={Antalya}, country={Turkey}, year={2014}}